Neoplastic diseases of the genitourinary (GU) system are the most common among all human systems in the United States, accounting for approximately 40% of all male cancers. Prostate, bladder, and kidney cancers rank first, fourth, and sixth, respectively, in terms of cancer incidence. Additionally, testicular cancer is the most common malignant disease in young men in the age group of 15-44 years. It is essential for pathologists and researchers to be updated with new developments in the diagnosis and research of GU cancers. For this special issue, we invite front-line pathologists and researchers to submit high-quality scientific manuscripts regarding GU cancers. Potential topics include, but are not limited to:
1. Cohort- or case- studies to characterize clinicopathologic features of GU cancers
2. New developments in diagnostic criteria
3. Use of biomarkers in diagnosis, prognosis, and prediction of therapeutic response
4. Laboratory investigations to implore the molecular mechanism underlying the development and progression